Two Sigma Securities’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-294
Closed -$11K 1436
2025
Q3
$11K Buy
+294
New +$16.9K ﹤0.01% 1210
2025
Q2
Sell
-78
Closed -$11.2K 1454
2025
Q1
$11.2K Buy
+78
New +$18.2K ﹤0.01% 1215
2024
Q4
Sell
-34
Closed -$6.41K 1596
2024
Q3
$6.41K Sell
34
-52
-60% -$8.26K ﹤0.01% 2654
2024
Q2
$17.2K Buy
+86
New +$33.9K ﹤0.01% 2727
2023
Q4
Sell
-6
Closed -$5.37K 2974
2023
Q3
$5.37K Buy
6
+1
+20% +$1.28K ﹤0.01% 2781
2023
Q2
$6.53K Hold
5
﹤0.01% 2646
2023
Q1
$8.08K Buy
+5
New +$9.41K ﹤0.01% 2485
2022
Q4
Sell
-5
Closed -$12K 2529
2022
Q3
$12K Buy
5
+2
+67% +$8.65K ﹤0.01% 2373
2022
Q2
$14K Buy
+3
New +$14K ﹤0.01% 1997
2020
Q3
Sell
-3
Closed -$27K 1275
2020
Q2
$27K Buy
+3
New +$18.1K ﹤0.01% 1281
2019
Q2
Sell
-1
Closed -$31K 2045
2019
Q1
$31K Buy
+1
New +$70.8K ﹤0.01% 1643
2018
Q4
Hold
0
-$16K 2093
2018
Q3
Hold
0
2465
2017
Q4
Hold
0
-$39K 1710
2017
Q3
Hold
0
765

Other funds holding AEMD

Two Sigma Securities's AEMD Position: Q4 2025 in Review

Two Sigma Securities sold out of Aethlon Medical (AEMD) in Q4 2025, closing a stake of 294 shares — an estimated $11K sold.

Two Sigma Securities first reported a position in AEMD in Q1 2019 and held it in 11 quarters. The position peaked at $31K in Q1 2019. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

  • Two Sigma Securities reported no remaining Aethlon Medical position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 294 Aethlon Medical shares in Q4 2025, an estimated $11K.
  • Two Sigma Securities first reported a position in Aethlon Medical in Q1 2019 and held it in 11 quarters.
  • Two Sigma Securities's Aethlon Medical position peaked at $31K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.